Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This prospective, one-arm study which will enroll participants with biopsy-proven DCIS
scheduled for diagnostic breast MRI for preoperative staging/extent of disease evaluation as
part of standard of care. Eligible participants will be consented for participation in the
research study which includes a directed breast PET/MRI with 18F-FES. 18F-FES uptake of the
known malignancy will be measured on the PET/MRI examination using standardized uptake values
(SUV) and tumor-to-normal tissue ratios.